Examining our COVID-19 response: an update from federal officials : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining the COVID-19 response, focusing on an update from federal officials, March 18, 2021.

Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author)
Format: Government Document eBook
Language:English
Published: Washington : U.S. Government Publishing Office, 2022.
Series:S. hrg. ; 117-175
Subjects:
Online Access:https://purl.fdlp.gov/GPO/gpo184568

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000nam a2200000 i 4500
001 in00004591199
006 m o d f
007 cr |||||||||||
008 220715s2022 dcu ob f000 0 eng c
005 20220812191107.9
024 8 |a 46-755  |q (GPO jacket number) 
035 |a (OCoLC)on1336020278 
040 |a GPO  |b eng  |e rda  |e pn  |c GPO  |d MvI 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
074 |a 1043-C (online) 
086 0 |a Y 4.L 11/4:S.HRG.117-175 
110 1 |a United States.  |b Congress.  |b Senate.  |b Committee on Health, Education, Labor, and Pensions,  |e author. 
245 1 0 |a Examining our COVID-19 response: an update from federal officials :  |b hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining the COVID-19 response, focusing on an update from federal officials, March 18, 2021. 
264 1 |a Washington :  |b U.S. Government Publishing Office,  |c 2022. 
300 |a 1 online resource (iii, 88 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a S. hrg. ;  |v 117-175 
504 |a Includes bibliographical references. 
500 |a GPO Cataloging Record Distribution Program (CRDP). 
511 0 |a Hearing witnesses: Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Kessler, David, M.D., Chief Science Officer, COVID Response, United States Department of Health and Human Services, Washington, DC; Marks, Peter, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Walensky, Rochelle, M.D., MPH, Director, United States Centers for Disease Control and Prevention, Atlanta, GA. 
518 |a Date of hearing: 2021-03-18. 
588 |a Description based on online resource; title from PDF title page (govinfo, viewed July 15, 2022). 
650 0 |a COVID-19 Pandemic, 2020-  |x Government policy  |z United States. 
650 0 |a COVID-19 (Disease)  |x Government policy  |z United States. 
650 0 |a COVID-19 (Disease)  |z United States  |x Prevention. 
650 0 |a Public health  |z United States. 
655 7 |a Legislative hearings.  |2 lcgft 
776 0 8 |i Print version:  |a United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.  |t Examining our COVID-19 response: an update from federal officials  |w (OCoLC)1336020237 
810 1 |a United States.  |b Congress.  |b Senate.  |t S. hrg. ;  |v 117-175. 
856 4 0 |u https://purl.fdlp.gov/GPO/gpo184568  |t 0 
999 f f |s 0f6c52e1-bdbc-43ce-b4d2-223f27e1a868  |i 0f6c52e1-bdbc-43ce-b4d2-223f27e1a868  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e Y 4.L 11/4:S.HRG.117-175  |h Superintendent of Documents classification 
998 f f |a Y 4.L 11/4:S.HRG.117-175  |t 0  |l Available Online